SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,679 | -95.0% | 1,767 | -91.2% | 0.00% | – |
| Q2 2023 | $133,812 | -61.5% | 19,972 | -62.6% | 0.00% | – |
| Q1 2023 | $347,510 | -57.1% | 53,381 | -43.8% | 0.00% | -100.0% |
| Q4 2022 | $810,469 | +40423.4% | 95,014 | +22630.6% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 418 | -43.5% | 0.00% | – |
| Q2 2022 | $3,000 | -85.0% | 740 | -87.0% | 0.00% | – |
| Q1 2022 | $20,000 | -58.3% | 5,684 | -21.7% | 0.00% | – |
| Q4 2021 | $48,000 | +92.0% | 7,255 | +186.6% | 0.00% | – |
| Q3 2021 | $25,000 | -19.4% | 2,531 | +155.9% | 0.00% | – |
| Q2 2021 | $31,000 | -16.2% | 989 | +17.6% | 0.00% | – |
| Q1 2021 | $37,000 | -94.7% | 841 | -94.4% | 0.00% | – |
| Q4 2020 | $699,000 | – | 15,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |